The Slow Adoption of Neoadjuvant Treatment for Clinical T4b Colon Cancer: A National Cancer Database Analysis
{{output}}
Background: Emerging data support the use of neoadjuvant treatment (NAT), particularly immunotherapy in microsatellite instability-high (MSI-H) tumors. We evaluate national trends in NAT utilization for clinical T4b colon cancers... ...
